Summary

Persistence Market Research has recently released a comprehensive report on the global Acute Kidney Injury Treatment market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

・Acute Kidney Injury Treatment Market Size (2026E): US$ 2.86 Bn
・Projected Market Value (2033F): US$ 4.57 Bn
・Global Market Growth Rate (CAGR 2026-2033): 6.8%

Acute Kidney Injury Treatment Market - Report Scope

The acute kidney injury treatment market encompasses the ecosystem of manufacturers, suppliers, and end-users engaged in the production, distribution, and application of acute kidney injury treatment products and solutions. The market serves a wide range of end-use industries, and rapid technological advancements alongside evolving end-user requirements are significantly influencing market expansion across major global regions.

Market Growth Drivers

Rising AKI incidence from aging populations, diabetes, hypertension, and surgical complications is escalating demand for renal replacement therapies and biomarker diagnostics.

Market Restraints

Elevated treatment expenses, limited access to dialysis infrastructure in underdeveloped areas, and reimbursement pressures constrain market expansion.

Market Opportunities

Portable dialysis systems, telemedicine platforms, and AI-driven risk assessment tools enable decentralized AKI management and expand patient access.

Key Questions Answered in the Report

・What are the major factors driving global demand for acute kidney injury treatment?
・Which product and injury type segments are witnessing the highest growth in the acute kidney injury treatment market?
・How is the competitive landscape evolving in the acute kidney injury treatment market?
・Who are the leading players in the acute kidney injury treatment market, and what strategies are they adopting?
・What are the emerging trends and long-term growth prospects for the global acute kidney injury treatment market?

Competitive Intelligence and Business Strategy

Leading players in the acute kidney injury treatment market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Companies are investing in R&D and sustainable practices while pursuing collaborations, mergers, and regional expansion to gain a competitive edge.

Key Companies Profiled

・Pfizer Inc.
・AstraZeneca
・Novartis AG
・Sanofi
・Fresenius Medical Care AG
・B. Braun SE
・Baxter
・Medtronic
・GE HealthCare
・Nipro Europe Group Companies

Market Segmentation

By Product
・Continuous Renal Replacement Therapy (CRRT)
・Intermittent Hemodialysis (IHD)
・Drug Therapy

By Injury Type
・Pre-renal Injury
・Intrinsic Renal Injury
・Post-renal Injury

By Region
・North America
・Europe
・East Asia
・South Asia & Oceania
・Middle East & Africa
・Latin America

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Acute Kidney Injury Treatment Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Acute Kidney Injury Treatment Market: Value Chain
2.4.1. List of Raw Material Suppliers
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter Five Force's Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape
3. Macro-Economic Factors
3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview
4. Price Trend Analysis, 2019-2033
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences
5. Global Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
5.1. Key Highlights
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size Analysis, 2019-2025
5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global Acute Kidney Injury Treatment Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2025
5.3.3. Current Market Size (US$ Mn) Forecast By Product, 2026-2033
5.3.3.1. Continuous Renal Replacement Therapy (CRRT)
5.3.3.2. Intermittent Hemodialysis (IHD)
5.3.3.3. Drug Therapy
5.4. Market Attractiveness Analysis: Product
5.5. Global Acute Kidney Injury Treatment Market Outlook: Injury Type
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis By Injury Type, 2019-2025
5.5.3. Current Market Size (US$ Mn) Forecast By Injury Type, 2026-2033
5.5.3.1. Pre-renal Injury
5.5.3.2. Intrinsic Renal Injury
5.5.3.3. Post-renal Injury
5.6. Market Attractiveness Analysis: Injury Type
6. Global Acute Kidney Injury Treatment Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2025
6.3. Current Market Size (US$ Mn) Forecast By Region, 2026-2033
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
7.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
7.4.1. By Product
7.4.2. By Injury Type
7.4.3. By Country: U.S. and Canada
7.5. Market Attractiveness Analysis
8. Europe Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
8.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
8.4.1. By Product
8.4.2. By Injury Type
8.4.3. By Country: Germany, Italy, France, U.K., Spain, Russia, Rest of Europe
8.5. Market Attractiveness Analysis
9. East Asia Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
9.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
9.4.1. By Product
9.4.2. By Injury Type
9.4.3. By Country: China, Japan, South Korea
9.5. Market Attractiveness Analysis
10. South Asia and Oceania Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
10.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
10.4.1. By Product
10.4.2. By Injury Type
10.4.3. By Country: India, ASEAN, Oceania, Rest of South Asia
10.5. Market Attractiveness Analysis
11. Latin America Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
11.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
11.4.1. By Product
11.4.2. By Injury Type
11.4.3. By Country: Brazil, Mexico, Rest of Latin America
11.5. Market Attractiveness Analysis
12. Middle East & Africa Acute Kidney Injury Treatment Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
12.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
12.4.1. By Product
12.4.2. By Injury Type
12.4.3. By Country: GCC Countries, South Africa, Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
13. Competitive Landscape
13.1. Market Share Analysis by Company, 2026
13.2. Competitive Dashboard
13.3. Company Profiles
13.3.1. Pfizer Inc.
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.1.3. Financial Overview
13.3.1.4. Business Strategies and Developments
13.3.2. AstraZeneca
13.3.2.1. Company Overview
13.3.2.2. Product Portfolio
13.3.2.3. Financial Overview
13.3.2.4. Business Strategies and Developments
13.3.3. Novartis AG
13.3.3.1. Company Overview
13.3.3.2. Product Portfolio
13.3.3.3. Financial Overview
13.3.3.4. Business Strategies and Developments
13.3.4. Sanofi
13.3.4.1. Company Overview
13.3.4.2. Product Portfolio
13.3.4.3. Financial Overview
13.3.4.4. Business Strategies and Developments
13.3.5. Fresenius Medical Care AG
13.3.5.1. Company Overview
13.3.5.2. Product Portfolio
13.3.5.3. Financial Overview
13.3.5.4. Business Strategies and Developments
13.3.6. B. Braun SE
13.3.6.1. Company Overview
13.3.6.2. Product Portfolio
13.3.6.3. Financial Overview
13.3.6.4. Business Strategies and Developments
13.3.7. Baxter
13.3.7.1. Company Overview
13.3.7.2. Product Portfolio
13.3.7.3. Financial Overview
13.3.7.4. Business Strategies and Developments
13.3.8. Medtronic
13.3.8.1. Company Overview
13.3.8.2. Product Portfolio
13.3.8.3. Financial Overview
13.3.8.4. Business Strategies and Developments
13.3.9. GE HealthCare
13.3.9.1. Company Overview
13.3.9.2. Product Portfolio
13.3.9.3. Financial Overview
13.3.9.4. Business Strategies and Developments
13.3.10. Nipro Europe Group Companies
13.3.10.1. Company Overview
13.3.10.2. Product Portfolio
13.3.10.3. Financial Overview
13.3.10.4. Business Strategies and Developments
14. Appendix
14.1. Research Methodology
14.2. Report Assumptions
14.3. Acronyms and Abbreviations